Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Peter M. Nilsson, Anna Kandell-Collén & H. Ingemar Andersson. (1997) Blood Pressure and Metabolic Factors in Relation to Chronic Pain. Blood Pressure 6:5, pages 294-298.
Read now
Read now
Claudio Letizia, Sandro Mazzaferro, Anita De Ciocchis, Sabrina Cerci, Santo Morabito, Giulio A. Cinotti & Domenico Scavo. (1996) Effects of Haemodialysis Session on Plasma Beta-Endorphin, ACTH and Cortisol in Patients with End-Stage Renal Disease. Scandinavian Journal of Urology and Nephrology 30:5, pages 399-402.
Read now
Read now
Articles from other publishers (12)
Manuel T. Velasquez, Sarah C. Andrews & Dominic S. Raj. 2020. Chronic Renal Disease. Chronic Renal Disease
225
248
.
Maria R. Wing, Dominic S. Raj & Manuel T. Velasquez. 2015. Chronic Renal Disease. Chronic Renal Disease
106
125
.
Robert H. MakWai Cheung. (2020) Adipokines and Gut Hormones in End-Stage Renal Disease. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 27:2_suppl, pages 298-302.
Crossref
Crossref
Mitsuhiro Isaka, Michiaki Imamura, Ichiro Sakuma, Yutaka Makino, Norihiko Shiiya & Keishu Yasuda. (2007) Cardiopulmonary bypass influences the plasma levels of calcitonin gene-related peptides in dogs: Effects of hemofiltration and hemodilution. Research in Veterinary Science 82:1, pages 110-114.
Crossref
Crossref
Erik Tingberg, Anders Roijer, Ulf Thilen & Hans Öhlin. (2006) Neurohumoral Changes in Patients With Left Ventricular Dysfunction Following Acute Myocardial Infarction and the Effect of Nitrate Therapy: A Randomized, Double-Blind, Placebo-Controlled Long-Term Study. Journal of Cardiovascular Pharmacology 48:4, pages 166-172.
Crossref
Crossref
Erik Tingberg, Ann-Kristin Öhlin, Anders Gottsäter & Hans Öhlin. (2006) Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy. International Journal of Cardiology 112:3, pages 275-281.
Crossref
Crossref
I. Odar‐Cederlöf & C. M. Kjellstrand. (2003) Cardiovasoactive Peptides in Hemodialysis Patients: Diagnostic Tools and Predictors of Outcome: A Review of Present Knowledge and Future Directions. Hemodialysis International 7:3, pages 222-231.
Crossref
Crossref
Juan Uriz, Pere Ginès, Rolando Ortega, Wladimiro Jiménez, Andrés Cárdenas, Blas Calahorra, Pau Sort, Javier Fernández, Ramón Bataller, Vicente Arroyo, Francisca Rivera & Juan Rodés. (2002) Increased plasma levels of neuropeptide Y in hepatorenal syndrome. Journal of Hepatology 36:3, pages 349-355.
Crossref
Crossref
G.I. Strauss, L. Edvinsson, F. Stolze Larsen, K. Møller & G.M. Knudsen. (2001) Circulating levels of neuropeptides (cgrp, vip, npy) in patients with fulminant hepatic failure. Neuropeptides 35:3-4, pages 174-180.
Crossref
Crossref
Martin Bald, Michael Gerigk & Wolfgang Rascher. (1997) Elevated plasma concentrations of neuropeptide Y in children and adults with chronic and terminal renal failure. American Journal of Kidney Diseases 30:1, pages 23-27.
Crossref
Crossref
Jörgen Hegbrant, Hans Thysell & Rolf Ekman. (1995) Circulating neuropeptide Y in plasma from uremic patients consists of multiple peptide fragments. Peptides 16:3, pages 395-397.
Crossref
Crossref
Isabelle Blazy, Mich�le D�chaux, Marina Charbit, Dani�le Brocart, Jean-Claude Souberbielle, Marie France Gagnadoux, Fran�ois Guillot & Charles Sachs. (1994) Endothelin-1 in children with chronic renal failure. Pediatric Nephrology 8:1, pages 40-44.
Crossref
Crossref